Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

Glaukos Corporation

GKOS
145,34
-4,67 (-3,11%)
11 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
25/1/202500:33EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
23/1/202513:00BWGlaukos to Release Fourth Quarter and Full Year 2024..
14/1/202522:05EDGAR2Form 8-K - Current report
14/1/202522:05BWGlaukos Announces Positive Clinical Updates for its iDose®..
03/1/202502:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202502:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202502:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202502:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/12/202403:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/12/202401:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202413:00BWGlaukos Submits New Drug Application to U.S. FDA for Epioxa™
20/12/202422:27EDGAR2Form 144 - Report of proposed sale of securities
20/12/202422:21EDGAR2Form 144 - Report of proposed sale of securities
17/12/202413:00BWGlaukos Announces Participation in the J.P. Morgan..
14/12/202401:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202418:32EDGAR2Form 144 - Report of proposed sale of securities
09/12/202412:30EDGAR2Form 8-K - Current report
03/12/202412:02EDGAR2Form 8-K - Current report
15/11/202413:00EDGAR2Form 8-K - Current report
08/11/202413:00BWGlaukos Announces Participation in Upcoming Investor..
04/11/202422:10EDGAR2Form 8-K - Current report
04/11/202422:05BWGlaukos Announces Third Quarter 2024 Financial Results
01/11/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202421:18EDGAR2Form 144 - Report of proposed sale of securities
17/10/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/10/202422:05BWGlaukos Announces Positive Topline Outcomes in Phase 3..
14/10/202413:00BWGlaukos To Present Multiple Scientific Abstracts at the 2024..
11/10/202423:27EDGAR2Form 8-K - Current report
09/10/202413:00BWGlaukos to Release Third Quarter 2024 Financial Results..
24/9/202401:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/9/202401:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/9/202401:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/9/202400:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202401:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/9/202421:03EDGAR2Form 144 - Report of proposed sale of securities
23/8/202423:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202422:19EDGAR2Form 144 - Report of proposed sale of securities
19/8/202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202413:00BWGlaukos Announces Participation in Upcoming Investor..
15/8/202423:12EDGAR2Form 144 - Report of proposed sale of securities
12/8/202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202413:00EDGAR2Form 8-K - Current report
09/8/202401:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202401:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202418:15EDGAR2Form 144 - Report of proposed sale of securities
02/8/202422:51EDGAR2Form 8-K/A - Current report: [Amend]
02/8/202422:44EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/7/202422:10EDGAR2Form 8-K - Current report
31/7/202422:05BWGlaukos Announces Second Quarter 2024 Financial Results
Apertura: 148,65 Min: 143,64 Max: 149,02
Chiusura: 150,01

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network